India to Philippines: Celecoxib Export Trade Route

The India to Philippines Celecoxib corridor is one of India's established pharmaceutical export routes, with 333 shipments documented worth a combined $13.7M USD. The route is dominated by BDH HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 27% of all export value, reflecting the consolidated nature of India's celecoxib manufacturing sector.

Across 46 active suppliers, the average shipment value stands at $41.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with celecoxib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 22.6%, placing it at rank #13 among India's top celecoxib export destinations globally.

On the import side, key buyers of Indian celecoxib in Philippines include NELPA LIFESCIENCES INC, AMB HK ENTERPRISES INC., AMB HK ENTERPRISES INC and 53 others. NELPA LIFESCIENCES INC is the single largest importer with 68 shipments valued at $10.4M USD.

India's celecoxib exports to Philippines are driven primarily by a handful of large-scale manufacturers. BDH HEALTHCARE PRIVATE LIMITED with 23 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 46 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BDH HEALTHCARE PRIVATE LIMITED, VINS INTERNATIONAL PRIVATE LIMITED, BDH INDUSTRIES LIMITED — together account for 68% of total trade value on this route. The average shipment value of $41.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products harmless medicine, saphlecox 200(celecoxib capsules 200mg ) (pack 10 x 10 c) and pharmaceutical products harmless medicine, saphlecox 200 (celecoxib capsule 200mg), suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NELPA LIFESCIENCES INC is the largest importer with 68 shipments worth $10.4M USD — representing 76% of all celecoxib imports from India on this route. A total of 56 buyers are active on this corridor.